A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy

Irida Kastrati, Marton I. Siklos, Svitlana D. Brovkovych, Gregory R.J. Thatcher, Jonna Frasor

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences